New CMS Measures: What to Know 👩🏼💻
Download eBook
→
877-349-4582
Request A Demo
Search
Solutions
EndoTool® Glucose Management System
EndoTool
®
IV
EndoTool
®
SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
877-349-4582
Request A Demo
877-349-4582
Request A Demo
Blog
Hypoglycemia
/
The Hypoglycemia “Cheat Sheet”
In our previous blog, we looked at the quick facts behind hyperglycemia and the personalized glucose management software to safely treat hyperglycemia while preventing hypoglycemia. While hyperglycemia often has the spotlight when it comes to blood glucose levels, hypoglycemia is just as alarming. Hypoglycemia is a condition characterized by abnormally low blood glucose levels, usually less than 70 mg/dL. If...
Hypoglycemia
Hyperglycemia
/
The Hyperglycemia “Cheat Sheet”
We are familiar with the link between hyperglycemia and increased mortality, even in patients who do not have diabetes. Our past blog posts have emphasized the importance of glucose control as a significant component of a patient’s health, particularly in intensive care environments. To create awareness for prevention, it is imperative to put emphasis on the facts. With regard to...
Hyperglycemia
EndoTool
,
IV Insulin Dosing
,
Residual Insulin
/
Monarch Announces Groundbreaking EREI Technology
This past Wednesday, the team at Monarch Medical Technologies announced ground-breaking EREI technology for any hospital scenario where intravenous insulin is administered. Dr. Patrick Burgess, founder and inventor of EndoTool, described the technology as having the potential to nearly eliminate severe hypoglycemia while removing the risk of human oversight. EREI refers to “estimated residual extracellular insulin” present in a patient’s...
EndoTool
IV Insulin Dosing
Residual Insulin
Nursing
/
Monarch Reflects on National Nurses Week
This past week was National Nurses Week, and the team at Monarch Medical Technologies would like to take this day to reflect on everything nurses do to enrich our lives. We would like to thank all nurses for the commitments and contributions they make in today’s healthcare and to raise awareness of their role. Additionally, Monarch Medical Technologies would like...
Nursing
EndoTool
/
Top 10 Reasons to Use EndoTool
Here are the top 10 reasons to use EndoTool: 10 – Confidence in Outcomes EndoTool is the market leader for safe glucose management for hospitalized patients and is trusted by more than 180 hospitals in the United States. 9 – Simple Process Once a facility begins using EndoTool, nurses follow a simple three-step process for safe dose recommendations. The process...
EndoTool
Surgical Site Infection
/
Surgical Site Infections and Prevention
According to the Centers for Disease Control and Prevention, a surgical site infection is an infection that occurs after surgery in the part of the body where the surgery took place. Surgical site infections can be less serious involving only the skin, or more severe encompassing tissues under the skin, organs, or implanted material. These infections develop in about 1...
Surgical Site Infection
ADA
,
Conferences
/
Monarch Participates in American Diabetes Association Tour de Cure Fundraiser
This April, Monarch Medical Technologies will participate in the 25th annual Tour de Cure hosted by the American Diabetes Association in Charlotte, North Carolina. The Tour de Cure is a series of fundraising cycling events held in 44 states nationwide to benefit the American Diabetes Association. Monarch Medical Technologies is thrilled to be involved with the community at this year’s Tour...
ADA
Conferences
Computerized Dosing
,
EndoTool
,
Glycemic Management
/
Inpatient Glucose Management: Part 3
Glucose Management Software This blog series has been used to educate our readers on inpatient glucose management. In part 1, we explored the risks and complications, and in part 2, we explored best practices recommended by the American Diabetes Association and The Joint Commission. In this post, we will come full circle with the benefits of inpatient glucose management software....
Computerized Dosing
EndoTool
Glycemic Management
ADA
,
Glycemic Management
,
The Joint Commission
/
Inpatient Glucose Management: Part 2
ADA and Joint Commission Guidelines for Best Practices In part 1 of this series, we explained the risks and complications associated with inpatient glucose control. We learned that occurrences include hyperglycemia, hypoglycemia, poor treatment and/or lack of control, and hospital-acquired conditions. The American Diabetes Association (ADA) and The Joint Commission have created recommendations for diabetes care in the hospital. Some...
ADA
Glycemic Management
The Joint Commission
Glycemic Management
/
Inpatient Glucose Management: Part 1
Risks and Complications Risks and complications associated with inpatient glucose control spark some of the most dreaded conversations exchanged in healthcare. Clinicians are accustomed with these situations and would prefer little or no occurrence. The detrimental obstacles include: Hyperglycemia – High blood sugar in hospitalized patients is common and associated with increased risk of infection, mortality and escalated cost. Hypoglycemia...
Glycemic Management
DKA
/
Diabetic Ketoacidoisis (DKA): What You Should Know
What is DKA? Diabetic ketoacidosis, or DKA, is a serious complication of diabetes that occurs when your body produces high levels of blood acids called ketones. How does DKA occur? When the body cannot produce enough insulin, the body begins to burn fat for energy and produces a buildup of acids in the bloodstream called ketones. Once the ketones build up...
DKA
CMS
/
How a Glucose Management System is Associated with Reimbursements
Every day, the United States fights the ongoing battle regarding the cost of healthcare. Reimbursement rates are dropping and hospitals question every expense in order to find justification for new tools and treatment options. The complex issue occurs when addressing all conditions, including hyperglycemia, a significant concern that is linked to higher mortality rates. Despite the understanding that manifestations of...
CMS
EndoTool
,
Personalized Dosing
,
Residual Insulin
/
Estimated Residual Extracellular Insulin (EREI): What Is It?
Estimated residual extracellular insulin, or EREI, refers to residual insulin present in a patient’s body. Every patient receiving insulin therapy requires personalized treatment based on their individual makeup. In addition to this, each patient’s need for insulin is not only different, but, ever-changing based on activity level, meals consumed and stress. The amount of residual insulin present in a person’s...
EndoTool
Personalized Dosing
Residual Insulin
EndoTool
,
IV Insulin Dosing
/
Study Compares EndoTool to Paper Protocol in the ICU
Everything is more intense in the intensive care unit (ICU). Critically ill patients demand more frequent and detailed monitoring as well as timely and precise interventions to address their fragile state. These patients health can be impacted by a wide range of factors, including blood sugar. Statistics show that approximately 30-50% of ICU patients experience stress-induced hyperglycemia, which is typically...
EndoTool
IV Insulin Dosing
EndoTool
,
Transition IV to SubQ
/
Streamlining the Transition from IV to SubQ Insulin
Intravenous (IV) insulin infusion is a standard protocol for treating critically ill hospitalized patients with hyperglycemia. However, once glucose levels stabilize, patients may be transitioned to subcutaneous (SubQ) insulin injections. The transition from IV to SubQ dosing involves many variables and can be difficult to achieve without a few bumps along the way. While some hospitals follow standard transition protocols,...
EndoTool
Transition IV to SubQ
Prev
1
2
3
4
5
6
7
8
9
Next
Search
Submit
Clear
Tags
Critical Care
Glycemic Control
Subcutaneous Insulin
Continuous Insulin Infusion
Hyperglycemia Management
Total Parenteral Nutrition
Insulin Therapy
A1C
ADA
CMS
Computerized Dosing
Conferences
Continuous Glucose Monitoring
Cost Savings
COVID-19
Diabetes
Diabetes Management
DKA
EMR Integration
EndoTool
Gestational Diabetes
Glycemic Management
Glycemic Steering Committee
Guidelines and Standards
Heart Failure
Hyperglycemia
Hypoglycemia
Hypothermia
Inpatient Glycemic Management
Insulin
Insulin Dosing
IV Insulin Dosing
Nursing
Obstetrics
Patient Safety
Performance Improvement
Personalized Dosing
Pharmacy
Renal Failure
Residual Insulin
SCCM
Society of Hospital Medicine
SubQ Insulin Dosing
Surgical Site Infection
The Joint Commission
Transition IV to SubQ
Trauma
Wearable Technology
Workflow
Search
Submit
Clear
Client Login
Search
Submit
Clear
Solutions
EndoTool® Glucose Management System
EndoTool
®
IV
EndoTool
®
SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
Case Study
Discover UPMC Central Pennsylvania's approach to a 92% reduction in hypoglycemia.
Download Case Study
Scroll Up